{"id":{"repo_id":"kennesaw","oai_identifier":"oai:digitalcommons.kennesaw.edu:integrbiol_etd-1071"},"canonical_url":"https://search.dev.ndltd.org/etd/kennesaw/oai:digitalcommons.kennesaw.edu:integrbiol_etd-1071","repository":{"repo_id":"kennesaw","name":"Kennesaw State University","base_url":"https://digitalcommons.kennesaw.edu/do/oai/"},"display":{"title":"Exploring the biofilm of Candida auris as it relates to persistence in clinical setting and susceptibility to antimicrobials","abstract":"<p>The rapid rise of drug-resistant pathogens is a global health concern. Known pathogens are acquiring resistance to many commonly used drugs, while new drug-resistant pathogens are emerging. These resistant pathogens are responsible for many healthcare-associated infections (HAI) [1, 2]. <em>Candida auris</em> is among these emerging drug-resistant pathogens, first described in 2009. The CDC labels <em>C. auris</em> at the highest level of global public health threat [3,4]. Effective methods of decolonization and control of the organisms have yet to be established, as it is resistant to many agents used for microbial control. Recent research has found that <em>C. auris </em>has the capacity to form biofilms on healthcare surfaces and human skin [1,2]. This research aims to evaluate the role of biofilm formation of <em>C. auris</em> in its heightened antimicrobial resistance and high transmissibility, causing outbreaks in clinical settings. This study will explore the biofilm formation of <em>C. auris</em>, focusing on structural characteristics, nutrient utilization, and antimicrobial resistance. <strong></strong></p>","abstract_html":"&lt;p&gt;The rapid rise of drug-resistant pathogens is a global health concern. Known pathogens are acquiring resistance to many commonly used drugs, while new drug-resistant pathogens are emerging. These resistant pathogens are responsible for many healthcare-associated infections (HAI) [1, 2]. &lt;em&gt;Candida auris&lt;/em&gt; is among these emerging drug-resistant pathogens, first described in 2009. The CDC labels &lt;em&gt;C. auris&lt;/em&gt; at the highest level of global public health threat [3,4]. Effective methods of decolonization and control of the organisms have yet to be established, as it is resistant to many agents used for microbial control. Recent research has found that &lt;em&gt;C. auris &lt;/em&gt;has the capacity to form biofilms on healthcare surfaces and human skin [1,2]. This research aims to evaluate the role of biofilm formation of &lt;em&gt;C. auris&lt;/em&gt; in its heightened antimicrobial resistance and high transmissibility, causing outbreaks in clinical settings. This study will explore the biofilm formation of &lt;em&gt;C. auris&lt;/em&gt;, focusing on structural characteristics, nutrient utilization, and antimicrobial resistance. &lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;","abstract_has_math":false,"creators":["Butts, bethany"],"institution":null,"degree_name":"Master of Science in Integrative Biology (MSIB)","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Dr. Martin Hudson","Dr. Melanie Griffin","Dr. Scott Nowak"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-12-16T08:00:00Z","date_published":"2021-12-16T08:00:00Z","updated_at":"2026-07-24T02:43:51Z","subjects":["Candida auris","Biofilms","Antimicrobial Susceptibility","fungal pathogen","Biology","Integrative Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.kennesaw.edu/integrbiol_etd/71","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Martin Hudson","Dr. Melanie Griffin","Dr. Scott Nowak"]},{"key":"dc:creator","label":"Author","values":["Butts, bethany"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-11-16T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Integrative Biology (MSIB)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Candida auris","Biofilms","Antimicrobial Susceptibility","fungal pathogen","Biology","Integrative Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.kennesaw.edu/integrbiol_etd/71"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>The rapid rise of drug-resistant pathogens is a global health concern. Known pathogens are acquiring resistance to many commonly used drugs, while new drug-resistant pathogens are emerging. These resistant pathogens are responsible for many healthcare-associated infections (HAI) [1, 2]. <em>Candida auris</em> is among these emerging drug-resistant pathogens, first described in 2009. The CDC labels <em>C. auris</em> at the highest level of global public health threat [3,4]. Effective methods of decolonization and control of the organisms have yet to be established, as it is resistant to many agents used for microbial control. Recent research has found that <em>C. auris </em>has the capacity to form biofilms on healthcare surfaces and human skin [1,2]. This research aims to evaluate the role of biofilm formation of <em>C. auris</em> in its heightened antimicrobial resistance and high transmissibility, causing outbreaks in clinical settings. This study will explore the biofilm formation of <em>C. auris</em>, focusing on structural characteristics, nutrient utilization, and antimicrobial resistance. <strong></strong></p>"]},{"key":"dc:title","label":"Title","values":["Exploring the biofilm of Candida auris as it relates to persistence in clinical setting and susceptibility to antimicrobials"]}]}],"canonical_facts":{"dc:contributor":["Dr. Martin Hudson","Dr. Melanie Griffin","Dr. Scott Nowak"],"dc:creator":["Butts, bethany"],"dc:date.available":["2023-11-16T08:00:00Z"],"dc:description.abstract":["<p>The rapid rise of drug-resistant pathogens is a global health concern. Known pathogens are acquiring resistance to many commonly used drugs, while new drug-resistant pathogens are emerging. These resistant pathogens are responsible for many healthcare-associated infections (HAI) [1, 2]. <em>Candida auris</em> is among these emerging drug-resistant pathogens, first described in 2009. The CDC labels <em>C. auris</em> at the highest level of global public health threat [3,4]. Effective methods of decolonization and control of the organisms have yet to be established, as it is resistant to many agents used for microbial control. Recent research has found that <em>C. auris </em>has the capacity to form biofilms on healthcare surfaces and human skin [1,2]. This research aims to evaluate the role of biofilm formation of <em>C. auris</em> in its heightened antimicrobial resistance and high transmissibility, causing outbreaks in clinical settings. This study will explore the biofilm formation of <em>C. auris</em>, focusing on structural characteristics, nutrient utilization, and antimicrobial resistance. <strong></strong></p>"],"dc:identifier":["https://digitalcommons.kennesaw.edu/integrbiol_etd/71"],"dc:subject":["Candida auris","Biofilms","Antimicrobial Susceptibility","fungal pathogen","Biology","Integrative Biology"],"dc:title":["Exploring the biofilm of Candida auris as it relates to persistence in clinical setting and susceptibility to antimicrobials"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science in Integrative Biology (MSIB)"]},"updated_at":"2026-07-24T02:43:51Z"}